✦ LIBER ✦

New frontiers in primary immunodeficiency disorders: immunology and beyond…

✍ Scribed by Eleonora Gambineri

Publisher: Springer
Year: 2011
Tongue: English
Weight: 155 KB
Volume: 69
Category: Article
ISSN: 1420-682X
DOI: 10.1007/s00018-011-0833-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Primary Immunodeficiency Diseases in Aus

Primary Immunodeficiency Diseases in Australia and New Zealand

✍ Philippa Kirkpatrick; Sean Riminton 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 443 KB

Frequency and Clinical Manifestations of

Frequency and Clinical Manifestations of Patients with Primary Immunodeficiency Disorders in Iran: Update from the Iranian Primary Immunodeficiency Registry

✍ NIMA REZAEI; ASGHAR AGHAMOHAMMADI; MOSTAFA MOIN; ZAHRA POURPAK; MASOUD MOVAHEDI; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 449 KB

Primary Immunodeficiency Disorders in th

Primary Immunodeficiency Disorders in the Republic of Ireland: First Report of the National Registry in Children and Adults

✍ M. ABUZAKOUK; C. FEIGHERY 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 110 KB

Progressive extrapyramidal disorder with

Progressive extrapyramidal disorder with primary hypogonadism and alopecia in sibs: A new syndrome?

✍ Devriendt, Koenraad; Legius, Eric; Fryns, Jean Pierre 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 15 KB 👁 2 views

We report on 2 sibs with consanguineous parents, and an identical progressive extrapyramidal movement disorder with onset in adolescence and associated with progressive alopecia and primary hypogonadism. To our knowledge, this syndrome has not been reported, and probably represents a newly recognize

Efficacy and Safety of a New 20% Immunog

Efficacy and Safety of a New 20% Immunoglobulin Preparation for Subcutaneous Administration, IgPro20, in Patients With Primary Immunodeficiency

✍ John B. Hagan; Mary B. Fasano; Sheldon Spector; Richard L. Wasserman; Isaac Mela 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 197 KB

Efficacy, Safety and Tolerability of a N

Efficacy, Safety and Tolerability of a New 10% Liquid Intravenous Immune Globulin [IGIV 10%] in Patients with Primary Immunodeficiency

✍ Joseph A. Church; Heinz Leibl; Mark R. Stein; Isaac R. Melamed; Arye Rubinstein; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 443 KB